エーザイの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/08/26 | 5,738 | 5,757 | 5,692 | 5,700 | -43 | -0.7% | 817,800 |
| 2022/08/25 | 5,729 | 5,812 | 5,722 | 5,743 | +73 | +1.3% | 1,029,400 |
| 2022/08/24 | 5,746 | 5,756 | 5,661 | 5,670 | -103 | -1.8% | 1,261,200 |
| 2022/08/23 | 5,817 | 5,817 | 5,745 | 5,773 | -51 | -0.9% | 1,709,100 |
| 2022/08/22 | 5,863 | 5,871 | 5,820 | 5,824 | -108 | -1.8% | 1,562,000 |
| 2022/08/19 | 6,060 | 6,079 | 5,932 | 5,932 | -125 | -2.1% | 986,200 |
| 2022/08/18 | 6,087 | 6,119 | 6,035 | 6,057 | -130 | -2.1% | 902,800 |
| 2022/08/17 | 6,204 | 6,227 | 6,178 | 6,187 | -18 | -0.3% | 835,900 |
| 2022/08/16 | 6,238 | 6,241 | 6,188 | 6,205 | ±0 | ±0% | 485,800 |
| 2022/08/15 | 6,141 | 6,212 | 6,140 | 6,205 | +90 | +1.5% | 491,500 |
| 2022/08/12 | 6,238 | 6,238 | 6,077 | 6,115 | +20 | +0.3% | 1,106,000 |
| 2022/08/10 | 6,102 | 6,119 | 6,040 | 6,095 | -4 | -0.1% | 538,300 |
| 2022/08/09 | 6,120 | 6,213 | 6,090 | 6,099 | -13 | -0.2% | 711,300 |
| 2022/08/08 | 5,985 | 6,130 | 5,980 | 6,112 | +71 | +1.2% | 779,800 |
| 2022/08/05 | 5,999 | 6,106 | 5,902 | 6,041 | +84 | +1.4% | 1,040,200 |
| 2022/08/04 | 6,000 | 6,030 | 5,928 | 5,957 | +22 | +0.4% | 589,700 |
| 2022/08/03 | 5,954 | 5,987 | 5,917 | 5,935 | +6 | +0.1% | 486,900 |
| 2022/08/02 | 6,057 | 6,093 | 5,915 | 5,929 | -168 | -2.8% | 863,900 |
| 2022/08/01 | 6,068 | 6,118 | 6,023 | 6,097 | +20 | +0.3% | 590,200 |
| 2022/07/29 | 6,131 | 6,151 | 6,028 | 6,077 | -53 | -0.9% | 972,700 |
| 2022/07/28 | 6,148 | 6,158 | 6,078 | 6,130 | +29 | +0.5% | 739,400 |
| 2022/07/27 | 6,097 | 6,129 | 6,052 | 6,101 | -1 | ±0% | 751,100 |
| 2022/07/26 | 6,132 | 6,138 | 6,034 | 6,102 | -5 | -0.1% | 806,600 |
| 2022/07/25 | 6,244 | 6,244 | 5,990 | 6,107 | -237 | -3.7% | 2,195,300 |
| 2022/07/22 | 6,350 | 6,422 | 6,282 | 6,344 | -3 | ±0% | 1,160,300 |
| 2022/07/21 | 6,200 | 6,347 | 6,193 | 6,347 | +77 | +1.2% | 928,800 |
| 2022/07/20 | 6,243 | 6,275 | 6,200 | 6,270 | +76 | +1.2% | 706,600 |
| 2022/07/19 | 6,271 | 6,280 | 6,132 | 6,194 | -91 | -1.4% | 1,155,700 |
| 2022/07/15 | 6,236 | 6,300 | 6,193 | 6,285 | +71 | +1.1% | 851,700 |
| 2022/07/14 | 6,150 | 6,235 | 6,150 | 6,214 | +62 | +1% | 626,700 |
| 2022/07/13 | 6,120 | 6,196 | 6,115 | 6,152 | -7 | -0.1% | 692,100 |
| 2022/07/12 | 6,172 | 6,244 | 6,130 | 6,159 | -22 | -0.4% | 961,200 |
| 2022/07/11 | 6,196 | 6,248 | 6,147 | 6,181 | +85 | +1.4% | 864,600 |
| 2022/07/08 | 6,190 | 6,190 | 6,030 | 6,096 | -57 | -0.9% | 1,251,100 |
| 2022/07/07 | 6,217 | 6,230 | 6,105 | 6,153 | -14 | -0.2% | 1,118,100 |
| 2022/07/06 | 5,860 | 6,264 | 5,860 | 6,167 | +342 | +5.9% | 2,748,600 |
| 2022/07/05 | 5,859 | 5,866 | 5,783 | 5,825 | ±0 | ±0% | 729,900 |
| 2022/07/04 | 5,789 | 5,840 | 5,765 | 5,825 | +134 | +2.4% | 796,300 |
| 2022/07/01 | 5,752 | 5,799 | 5,661 | 5,691 | -34 | -0.6% | 783,500 |
| 2022/06/30 | 5,787 | 5,817 | 5,690 | 5,725 | -75 | -1.3% | 1,156,000 |
| 2022/06/29 | 5,708 | 5,832 | 5,692 | 5,800 | +88 | +1.5% | 1,479,700 |
| 2022/06/28 | 5,616 | 5,715 | 5,578 | 5,712 | +92 | +1.6% | 813,000 |
| 2022/06/27 | 5,594 | 5,662 | 5,577 | 5,620 | +59 | +1.1% | 851,000 |
| 2022/06/24 | 5,556 | 5,583 | 5,491 | 5,561 | +77 | +1.4% | 882,200 |
| 2022/06/23 | 5,377 | 5,488 | 5,366 | 5,484 | +132 | +2.5% | 855,900 |
| 2022/06/22 | 5,296 | 5,371 | 5,272 | 5,352 | +68 | +1.3% | 773,500 |
| 2022/06/21 | 5,228 | 5,295 | 5,198 | 5,284 | +94 | +1.8% | 776,000 |
| 2022/06/20 | 5,196 | 5,198 | 5,136 | 5,190 | +81 | +1.6% | 716,200 |
| 2022/06/17 | 5,031 | 5,110 | 5,011 | 5,109 | -34 | -0.7% | 1,503,800 |
| 2022/06/16 | 5,161 | 5,194 | 5,131 | 5,143 | +59 | +1.2% | 678,800 |
551～
600
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「エーザイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| 協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| 小野薬 | 174,700円 | -3.5% | -50.2% | 4.58% | 14.15倍 | 1.05倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
